Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Burgdorf, Kristoffer Sølvsten ^a,b   Grarup, Niels ^a   Justesen, Johanne Marie ^a   Harder, Marie Neergaard ^a   Witte, Daniel Rinse ^c   Jørgensen, Torben ^d,e   Sandbæk, Annelli ^f   Lauritzen, Torsten ^f   Madsbad, Sten ^b,e   Hansen, Torben ^a,g   Pedersen, Oluf ^a,e,f  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c STENO DIABETES CENTER   (Denmark)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f AARHUS UNIVERSITY   (Denmark)

^g UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUCOSE; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INSULIN; PHOSPHODIESTERASE I; PROLINE; PROTEIN ENPP1; PROTEIN P53; PROTEIN RAPGEF1; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR NRF1; UNCLASSIFIED DRUG; TP53 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; EUROPE; FEMALE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPIC VARIATION; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CAUCASIAN; GENETICS; META ANALYSIS;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79251632612     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015813     Document Type: Article

References (23)

1. McCarthy MI, Zeggini E (2009) Genome-wide association studies in type 2 diabetes. Curr Diab Rep 9: 164-71.
2. Gaulton KJ, Willer CJ, Li Y, Scott LJ, Conneely KN, et al. (2008) Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes 57: 3136-3144.
3. Gaulton KJ, Mohlke KL, Vision TJ (2007) A computational system to select candidate genes for complex human traits. Bioinformatics 23: 1132-1140.
4. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, et al. (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20: 284-287.
5. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, et al. (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 10: 377-386.
6. Glumer C, Jorgensen T, Borch-Johnsen K (2003) Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 26: 2335-2340.
7. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, et al. (2000) The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 24: 6-11.
8. World Health Organization Study Group (1999) Part 1: Diagnosis and classification of diabetes mellitus. In Tech. Rep. Ser.,World Health Organization, 36.
9. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42: 579-589.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
11. Hansen T, Drivsholm T, Urhammer SA, Palacios RT, Vølund A, et al. (2007) The BIGTT test. A novel test for simultaneous measurement of pancreatic b-cell function, insulin sensitivity, and glucose tolerance. Diabetes Care 2007 30: 257-262.
12. R Development Core Team (1999) R: A language and environment for statistical computing, R Foundation for Statistical Computering, Vienna, Australia ISBN 3-900051-01-0. Available: http://www.R-project.org.
13. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, et al. (2007) Restoration of p53 function leads to tumour regression in vivo. Nature 445: 661-665.
14. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7: 248-249.
15. Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, et al. (2000) A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 25: 47-54.
16. Perry JR, Weedon MN, Langenberg C, Jackson AU, Lyssenko V, et al. (2010) Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet 1: 535-544.
17. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, et al. (2009) Sex hormonebinding globulin and risk of type 2 diabetes in women and men. N Engl J Med 17: 1152-1163.
18. Almeida LO, Custódio AC, Pinto GR, Santos MJ, Almeida JR, et al. (2009) Polymorphisms and DNA methylation of gene TP53 associated with extra-axial brain tumors. Genet Mol Res 6: 8-18.
19. Han JY, Lee GK, Jang DH, Lee SY, Lee JS (2008) Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer. Cancer 113: 799-807.
20. Ørsted DD, Bojesen SE, Tybjærg-Hansen A, Nordestgaard BG (2007) Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population. J Exp Medol 204: 1295-1301.
21. Baratta R, Rossetti P, Prudente S, Barbetti F, Sudano D, et al. (2008) Role of the ENPP1 K121Q polymorphism in glucose homeostasis. Diabetes 57: 3360-3364.
22. Pizzuti A, Frittitta L, Argiolas A, Baratta R, Goldfine ID, et al. (1999) A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 48: 1881-1884.
23. McAteer JB, Prudente S, Bacci S, Lyon HN, Hirschhorn JN, et al. (2008) The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations evidence from an updated meta-analysis in 42,042 subjects. Diabetes 57: 1125-30.